News

KREAXI TV

Press Release

Amolyt Pharma selected for the French Tech 120 Program

Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced that the company has been selected for the French Tech FT120, a support program for French late-stage startups by the French State....

Amolyt Pharma Announces Appointment of Two Directors

Amolyt Pharma, a global company specializingin developing therapeutic peptides for rare endocrine and metabolic diseases, today announced that the company has made two appointments to its Board of Directors following its Annual General Meeting, which was held on June...